Neurocrine Biosciences Inc - Net Worth and Insider Trading
Neurocrine Biosciences Inc Net Worth
The estimated net worth of Neurocrine Biosciences Inc is at least $59 Million dollars as of 2024-11-13. Neurocrine Biosciences Inc is the 10% Owner of Voyager Therapeutics Inc and owns about 8,575,316 shares of Voyager Therapeutics Inc (VYGR) stock worth over $59 Million. Details can be seen in Neurocrine Biosciences Inc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Neurocrine Biosciences Inc has not made any transactions after 2023-02-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Neurocrine Biosciences Inc
Neurocrine Biosciences Inc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Neurocrine Biosciences Inc owns 1 companies in total, including Voyager Therapeutics Inc (VYGR) .
Click here to see the complete history of Neurocrine Biosciences Inc’s form 4 insider trades.
Insider Ownership Summary of Neurocrine Biosciences Inc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VYGR | Voyager Therapeutics Inc | 2023-02-23 | 10 percent owner |
Neurocrine Biosciences Inc Latest Holdings Summary
Neurocrine Biosciences Inc currently owns a total of 1 stock. Neurocrine Biosciences Inc owns 8,575,316 shares of Voyager Therapeutics Inc (VYGR) as of February 23, 2023, with a value of $59 Million.
Latest Holdings of Neurocrine Biosciences Inc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics Inc | 2023-02-23 | 8,575,316 | 6.83 | 58,569,408 |
Holding Weightings of Neurocrine Biosciences Inc
Neurocrine Biosciences Inc Form 4 Trading Tracker
According to the SEC Form 4 filings, Neurocrine Biosciences Inc has made a total of 1 transactions in Voyager Therapeutics Inc (VYGR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Voyager Therapeutics Inc is the acquisition of 4,395,588 shares on February 23, 2023, which cost Neurocrine Biosciences Inc around $39 Million.
Insider Trading History of Neurocrine Biosciences Inc
- 1
Neurocrine Biosciences Inc Trading Performance
GuruFocus tracks the stock performance after each of Neurocrine Biosciences Inc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Neurocrine Biosciences Inc is 56.57%. GuruFocus also compares Neurocrine Biosciences Inc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Neurocrine Biosciences Inc within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Neurocrine Biosciences Inc's insider trading performs compared to the benchmark.
Performance of Neurocrine Biosciences Inc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.04 | | | | | |
| Relative Return to S&P 500(%) | 11.76 | | | | | |
Neurocrine Biosciences Inc Ownership Network
Ownership Network List of Neurocrine Biosciences Inc
Ownership Network Relation of Neurocrine Biosciences Inc
Neurocrine Biosciences Inc Owned Company Details
What does Voyager Therapeutics Inc do?
Who are the key executives at Voyager Therapeutics Inc?
Neurocrine Biosciences Inc is the 10 percent owner of Voyager Therapeutics Inc. Other key executives at Voyager Therapeutics Inc include Chief Legal Officer Sandell Jacquelyn Fahey , Chief Operating Officer Robin Swartz , and Chief Scientific Officer Todd Alfred Carter .
Voyager Therapeutics Inc (VYGR) Insider Trades Summary
Over the past 18 months, Neurocrine Biosciences Inc made no insider transaction in Voyager Therapeutics Inc (VYGR). Other recent insider transactions involving Voyager Therapeutics Inc (VYGR) include a net sale of 21,233 shares made by Todd Alfred Carter , a net sale of 7,866 shares made by Robin Swartz , and a net sale of 25,148 shares made by Alfred Sandrock .
In summary, during the past 3 months, insiders sold 5,999 shares of Voyager Therapeutics Inc (VYGR) in total and bought 0 shares, with a net sale of 5,999 shares. During the past 18 months, 77,577 shares of Voyager Therapeutics Inc (VYGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 77,577 shares.
Voyager Therapeutics Inc (VYGR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Voyager Therapeutics Inc Insider Transactions
Neurocrine Biosciences Inc Mailing Address
Above is the net worth, insider trading, and ownership report for Neurocrine Biosciences Inc. You might contact Neurocrine Biosciences Inc via mailing address: 12780 El Camino Real, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
